150 related articles for article (PubMed ID: 23851431)
1. Rare ALK expression but no ALK rearrangement in pancreatic ductal adenocarcinoma and neuroendocrine tumors.
Graham RP; Oliveira AM; Zhang L
Pancreas; 2013 Aug; 42(6):949-51. PubMed ID: 23851431
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
[TBL] [Abstract][Full Text] [Related]
3. Identification of Targetable
Singhi AD; Ali SM; Lacy J; Hendifar A; Nguyen K; Koo J; Chung JH; Greenbowe J; Ross JS; Nikiforova MN; Zeh HJ; Sarkaria IS; Dasyam A; Bahary N
J Natl Compr Canc Netw; 2017 May; 15(5):555-562. PubMed ID: 28476735
[TBL] [Abstract][Full Text] [Related]
4. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA
Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
[TBL] [Abstract][Full Text] [Related]
5. The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
Betz BL; Dixon CA; Weigelin HC; Knoepp SM; Roh MH
Cancer Cytopathol; 2013 Sep; 121(9):489-99. PubMed ID: 23536384
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of topoisomerase IIa expression in pancreatic ductal adenocarcinoma: a pilot study using chromogenic in situ hybridization and immunohistochemistry on tissue microarrays.
Tsiambas E; Karameris A; Tiniakos DG; Karakitsos P
Pancreatology; 2007; 7(1):45-52. PubMed ID: 17449965
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH.
Hutarew G; Hauser-Kronberger C; Strasser F; Llenos IC; Dietze O
Histopathology; 2014 Sep; 65(3):398-407. PubMed ID: 24612196
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical screening and fluorescence in situ hybridization confirmation of ALK translocation in lung adenocarcinoma and its clinicopathological significance: a single-center large-scale investigation of Chinese patients.
Wang WY; Liang DN; Yao WQ; Wu WL; Li JN; Chen M; Liao DY; Zhang M; Li GD
Hum Pathol; 2014 Jul; 45(7):1414-22. PubMed ID: 24775606
[TBL] [Abstract][Full Text] [Related]
9. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.
Peracaula R; Cleary KR; Lorenzo J; de Llorens R; Frazier ML
Cancer; 2000 Sep; 89(6):1252-8. PubMed ID: 11002220
[TBL] [Abstract][Full Text] [Related]
10. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
Pailler E; Adam J; Barthélémy A; Oulhen M; Auger N; Valent A; Borget I; Planchard D; Taylor M; André F; Soria JC; Vielh P; Besse B; Farace F
J Clin Oncol; 2013 Jun; 31(18):2273-81. PubMed ID: 23669222
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
13. EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays.
Tsiambas E; Karameris A; Lazaris AC; Talieri M; Triantafillidis JK; Cheracakis P; Manaios L; Gerontopoulos K; Patsouris E; Lygidakis NJ
Hepatogastroenterology; 2006; 53(69):452-7. PubMed ID: 16795991
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
Park HS; Lee JK; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS
Lung Cancer; 2012 Aug; 77(2):288-92. PubMed ID: 22465695
[TBL] [Abstract][Full Text] [Related]
16. ALK expression is absent in pancreatic ductal adenocarcinoma.
Ormanns S; Assmann G; Reu S; Gallmeier E; Bader DC; Kleespies A; Haas M; Kruger S; Heinemann V; Kirchner T; Boeck S
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1625-8. PubMed ID: 25017418
[TBL] [Abstract][Full Text] [Related]
17. Amplification but not translocation of anaplastic lymphoma kinase is a frequent event in oesophageal cancer.
Schoppmann SF; Streubel B; Birner P
Eur J Cancer; 2013 May; 49(8):1876-81. PubMed ID: 23490651
[TBL] [Abstract][Full Text] [Related]
18. ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma.
Popat S; Gonzalez D; Min T; Swansbury J; Dainton M; Croud JG; Rice AJ; Nicholson AG
Lung Cancer; 2012 Mar; 75(3):300-5. PubMed ID: 21855164
[TBL] [Abstract][Full Text] [Related]
19. For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibody.
Taheri D; Zahavi DJ; Del Carmen Rodriguez M; Meliti A; Rezaee N; Yonescu R; Ricardo BF; Dolatkhah S; Ning Y; Bishop JA; Netto GJ; Sharma R
Virchows Arch; 2016 Sep; 469(3):345-50. PubMed ID: 27271275
[TBL] [Abstract][Full Text] [Related]
20. Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation.
Perkins SL; Pickering D; Lowe EJ; Zwick D; Abromowitch M; Davenport G; Cairo MS; Sanger WG
Br J Haematol; 2005 Dec; 131(5):624-7. PubMed ID: 16351638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
